Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1950018Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$2.2M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#4,571
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Behnam Badie as a PI. Multi-PI records show the full award amount for context.
- 5R01CA236500-06R01Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant glioma$809.9Kaward amount
- 5R01CA254271-05R01Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma$711.8Kaward amount
- 5R01NS134116-02R01Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation$570.5Kaward amount
- 5U19CA264512-04U19Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability$94.8Kaward amount
Award organization
Organizations that administered FY2024 awards listing Behnam Badie as a PI.
FY2024 award administered by Beckman Research Institute/City of Hope (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardBeckman Research Institute/City of Hope
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4571
- 2024Entered Top 25% NationallyRanked #4571
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Behnam Badie.